Equity Incentive Plan (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of share-based compensation expense

The Company recorded share-based compensation expense in the following expense categories in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2023 and 2022:

	Year ended December 31,
	2023		2022
General and administrative	$	1,655	$	1,527
Sales and marketing	259		173
Research and development	432		323
Cost of revenues	125		89
Total	$	2,471	$	2,112

Schedule of fair value of stock options and stock appreciation rights weighted average assumptions

The grant date fair value of stock options and stock appreciation rights was estimated using the Black-Scholes option-pricing model with the following weighted average assumptions:

	Year ended December 31,
	2023		2022
Expected term (in years)	5.9		5.9
Expected Volatility	57.1	%	54.8	%
Risk-free rate	4.0	%	2.2	%
Dividend rate	—		—

Schedule of stock options and stock appreciate rights activity

The following table summarizes stock option and SARs activity for the year ended December 31, 2023:

Stock Options and Stock Appreciation Rights	Number of Shares under Option Plan	Weighted- Average Exercise Price per Option		Weighted- Average Remaining Contractual Life (in years)
Outstanding at December 31, 2022	8,234,823	$	1.82	7.7
Granted	1,784,446	2.19
Exercised	(442,573)	$	1.32
Forfeited and expired	(234,107)	$	2.49
Outstanding at December 31, 2023	9,342,589	$	1.94	7.2
Exercisable at December 31, 2023	6,028,787	$	1.64	6.6
Vested and expected to vest at December 31, 2023	9,342,589	$	1.94	7.2

Schedule of restricted stock units and stock bonus awards activity

RSUs and Stock Awards	Number of Shares under Option Plan	Weighted Average Grant Date Fair Value
Outstanding at December 31, 2022	263,155	$	1.90
Granted	320,097	$	4.91
Vested	(272,264)	$	2.02
Forfeited and expired	(7,300)	$	4.15
Outstanding at December 31, 2023	303,688	$	4.91